Skip to main content
Top
Published in: Journal of Nephrology 1/2021

01-02-2021 | Vesicorenal Reflux | Lesson for the Clinical Nephrologist

Attention to detail: not simple bed wetting—Hinman–Allen syndrome

Authors: Sai Sudha Mannemuddhu, Christopher E. Bayne, Naile Tufan Pekkucuksen, Lawrence R. Shoemaker

Published in: Journal of Nephrology | Issue 1/2021

Login to get access

Excerpt

A 15-year-old autistic female with primary nocturnal enuresis and secondary daytime incontinence without urgency, presented with UTI. Chemistries revealed: BUN 203 mg/dL, and creatinine 15.7 mg/dL. Hemodialysis (HD) was initiated. Urine specific gravity (SG) ranged 1.005–1.012. Sonography (RBUS) revealed severe bilateral hydroureteronephrosis and a large trabeculated bladder. Voiding cystourethrography (VCUG) revealed grade I vesicoureteral reflux (VUR) on the right and a trabeculated bladder with diverticula. MRI spine was normal. Foley bladder decompression improved creatinine (5.7 mg/dL), BUN (58 mg/dL) and bilateral hydroureteronephrosis (Fig. 1a). Video urodynamic study (VUDS) demonstrated a compliant bladder without uninhibited contractions but decreased filling sensation. Voiding was associated with prominent valsalva activity in the abdominal pressure lead and substantial electromyography (EMG) activity when patient emptied a minimal volume (Fig. 1b). Fluoroscopy captured an open bladder neck with beaking of the urethra at a closed external urinary sphincter (Fig. 1b) consistent with detrusor-external sphincter dyssynergia (DSD), a hallmark of Hinman–Allen syndrome (HS). Patient is currently on chronic HD and underwent appendicovesicostomy and reduction cystoplasty awaiting a kidney transplant.
Literature
1.
go back to reference Franco I (2012) Functional bladder problems in children: pathophysiology, diagnosis, and treatment. Pediatr Clin N Am 59:783–817CrossRef Franco I (2012) Functional bladder problems in children: pathophysiology, diagnosis, and treatment. Pediatr Clin N Am 59:783–817CrossRef
2.
go back to reference Leclair MD, Héloury Y (2010) Non-neurogenic elimination disorders in children. J Pediatr Urol 6:338–345CrossRef Leclair MD, Héloury Y (2010) Non-neurogenic elimination disorders in children. J Pediatr Urol 6:338–345CrossRef
3.
go back to reference Phillips E, Uehling DT (1993) Hinman syndrome: a vicious cycle. Urology 42:317–319 (discussion 9–20)CrossRef Phillips E, Uehling DT (1993) Hinman syndrome: a vicious cycle. Urology 42:317–319 (discussion 9–20)CrossRef
4.
go back to reference Farhat W, Bägli DJ, Capolicchio G, O'Reilly S, Merguerian PA, Khoury A et al (2000) The dysfunctional voiding scoring system: quantitative standardization of dysfunctional voiding symptoms in children. J Urol 164:1011–1015CrossRef Farhat W, Bägli DJ, Capolicchio G, O'Reilly S, Merguerian PA, Khoury A et al (2000) The dysfunctional voiding scoring system: quantitative standardization of dysfunctional voiding symptoms in children. J Urol 164:1011–1015CrossRef
5.
go back to reference Buckley BS, Sanders CD, Spineli L, Deng Q, Kwong JS (2019) Conservative interventions for treating functional daytime urinary incontinence in children. Cochrane Database Syst Rev 9:CD012367PubMed Buckley BS, Sanders CD, Spineli L, Deng Q, Kwong JS (2019) Conservative interventions for treating functional daytime urinary incontinence in children. Cochrane Database Syst Rev 9:CD012367PubMed
Metadata
Title
Attention to detail: not simple bed wetting—Hinman–Allen syndrome
Authors
Sai Sudha Mannemuddhu
Christopher E. Bayne
Naile Tufan Pekkucuksen
Lawrence R. Shoemaker
Publication date
01-02-2021
Publisher
Springer International Publishing
Published in
Journal of Nephrology / Issue 1/2021
Print ISSN: 1121-8428
Electronic ISSN: 1724-6059
DOI
https://doi.org/10.1007/s40620-020-00810-4

Other articles of this Issue 1/2021

Journal of Nephrology 1/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine